Your search history is turned on.
Date: February 13, 2023 Jurisdictions: Alberta, British Columbia, Manitoba, Newfoundland and Labrador, Nova Scotia, Ontario, Quebec, Saskatchewan
IMV Inc. Presents Positive Initial Results From The MVP-S Phase 2B VITALIZE Trial Early analysis reveals clinically meaningful activity in refractory DLBCL patients Multiple confirmed complete responses observed in heavily pre-treated patients No adverse safety and tolerability signal reported, consistent with previous clinical trials ...
Date: January 9, 2023 Jurisdictions: Alberta, British Columbia, Manitoba, Newfoundland and Labrador, Nova Scotia, Ontario, Quebec, Saskatchewan
IMV Inc. Announces Update and Planned 2023 Milestones to Advance Clinical Development of its Lead Therapeutic, MVP-S Presenting details on initial response data from the ongoing VITALIZE DLBCL trial at the Immuno-Oncology 360 conference on February 10, 2023 Expects preliminary clinical response data from the AVALON Phase 2b tr...
Date: December 22, 2022 Jurisdictions: Alberta, British Columbia, Manitoba, Newfoundland and Labrador, Nova Scotia, Ontario, Quebec, Saskatchewan
Wt_Cert 1 EXHIBIT A-1 COMMON SHARE PURCHASE WARRANT IMV INC. Warrant Shares: ______ Initial Exercise Date: December ___, 2022 THIS COMMON SHARE PURCHASE WARRANT (the Warrant) certifies that, for value received, ________ or its assigns (the Holder) is entitled, upon the...
Shelf SPA with Warrants.1.DOC 1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this Agreement) is dated as of December 16, 2022, between IMV Inc., a corporation incorporated under the Canada Business Corporations Act (the Company), and each purchaser identified on the signature pages ...
Pre_Funded_Wt_Cert 1 EXHIBIT A-2 PREFUNDED COMMON SHARE PURCHASE WARRANT IMV INC. Warrant Shares: ______ Initial Exercise Date: December ___, 2022 THIS PREFUNDED COMMON SHARE PURCHASE WARRANT (the Warrant) certifies that, for value received, ________ or its assigns (the ...
IMV - Declaration de changement important ANNEXE 51-102A3 DCLARATION DE CHANGEMENT IMPORTANT DIMV INC. 1. Dnomination et adresse de la socit IMV Inc. ( IMV ou la socit ) 130, Eileen Stubbs Avenue, bureau 19, Dartmouth (Nouvelle-cosse) B3B 2C4 ...
Date: December 20, 2022 Jurisdictions: Alberta, British Columbia, Manitoba, Newfoundland and Labrador, Nova Scotia, Ontario, Quebec, Saskatchewan
FORM 51-102F3 MATERIAL CHANGE REPORT OF IMV INC. 1. Name and Address of Corporation IMV Inc. (IMV or the Corporation) 130 Eileen Stubbs Avenue, Suite 19, Dartmouth, Nova Scotia B3B 2C4 2. Date of Material Change December 20, 2022 3. News Release On December 16 and Decembe...
Microsoft Word - IMV RD Press Release (Closing)_FINAL (002).doc 137612703v2 Media Release IMV Announces Closing of US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass., December 20, 2022--(BUSINESS WIRE)--IMV Inc. (IMV or the Company) (NASDAQ: IMV; TSX: IMV), a clinical-stage bioph...
IMV Prospectus Supplement Warrant Shares 2022 Registered Direct Offering (HCW) No securities regulatory authority has expressed an opinion about these securities and it is an offence to claim otherwise. This prospectus supplement (the Prospectus Supplement), together with the accompanying short form base shelf prospectus d...
McT_Consent_Wt_Shares_Supp McCarthy Ttrault S.E.N.C.R.L., s.r.l. 500, Grande Alle Est, 9e tage Qubec, QC G1R 2J7 Canada December 19, 2022 VIA SEDAR Nova Scotia Securities Commission Dear Sirs/Mesdames: Re: IMV Inc. (the Corporation) We refer you to the prospectus supplement d...